You searched for Alzheimer's - Page 14 of 30

News and Trends 26 Nov 2015

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

…with a broad neurological drug portfolio to include other indications like Alzheimer’s, Schizophrenia and ADHD. Founded by Fiona Marshall (one of our Top 10 UK Women in Biotech), she now…

November 26, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 29 Jul 2016

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

…implicated in a wide range of diseases that are a substantial burden on modern healthcare systems. For example type II diabetes, gout, Rheumatoid arthritis, Alzheimer’s disease and Cancer. Until recently,…

July 29, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 13 Feb 2017

Biotech from the Bermuda Islands Brings Good News for Dementia Patients

…Phase II for REM sleep behavior disorder (RBD), and the company intends to initiate programs for psychosis in Alzheimer’s and Parkinson’s. The company’s lead candidate, intepirdine (RVT-101), was also acquired…

February 13, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 May 2021

Startup Creator Launched to Fill Europe’s Microbiome Translational Gap

…phase III trials, joining a growing class of drug candidates for indications like chemotherapy-related infections and Alzheimer’s disease. While incubators, venture funds, and accelerators address part of the translational gap,…

May 28, 2021 - 6 minutesmins - By Mark Zipkin

Screenshot 2016 10 18 at 5.42.27 PM e1476805403921

News and Trends 18 Oct 2016

This New Biotech wants to Regrow Neurons to cure Parkinson’s

…for more info!. Parkinson’s affects more than 10 million people worldwide. Like other neurodegenerative diseases such as Alzheimer’s or Huntington’s, current treatments cannot stop its progression, only deal with the…

October 18, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Nov 2015

Get to Know the Top 50 Women in the UK’s Biotech Scene

…As Founder, Fiona is also the CSO of the Japanese Biopharma Sosei, which acquired Heptares this year in a €373M deal for their pipeline of neurological drugs for Alzheimer’s, ADHD,…

November 20, 2015 - 5 minutesmins - By Dani Bancroft

News and Trends 30 Sep 2019

Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close

…2017, Eli Lilly decided to walk away from the agreement – possibly due to the Phase III failure of its Alzheimer’s drug. This has left Adocia without a partner to…

September 30, 2019 - 4 minutesmins - By Editorial Team

News and Trends 22 Mar 2016

5 Cool Biotechs in Eastern Europe

…ovarian cancer and a phase I/II for non-small cell lung cancer (NSCLC). Axon Neuroscience is developing immunotherapies for Alzheimer’s disease and other neurodegenerative conditions. Based in Bratislava (Slovakia), it is…

March 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 2 Oct 2017

CRISPR Gets Snubbed Again by the Nobel Prize Committee

…well-being. This new approach could be particularly helpful for conditions that we haven’t had much luck with so far, for example, Alzheimer’s. A disrupted circadian rhythm and sleeping pattern is…

October 2, 2017 - 3 minutesmins - By Alex Dale

AlzProtect crowdfunding neurodegenerative disease

News and Trends 15 Feb 2017

French Biotech bids for Crowdfunding in Neurodegenerative Disease

…company has two other early-stage candidates with indications including Alzheimer’s. Currently, approved drugs for neurodegenerative diseases can treat symptoms but not stop the progression of the disease. AlzProtect’s strategy to…

February 15, 2017 - 2 minutesmins - By External Contributor

News and Trends 25 Jun 2018

Cambridge Biotech Raises €32M Series A Round to Treat Chronic Inflammation

…A round in 2016 to develop treatments for Alzheimer’s, Parkinson’s, heart disease and cancer. While chronic inflammation may sound like a small inconvenience, it can result in serious conditions like…

June 25, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 28 Apr 2016

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

…Alzheimer’s – and the increasing incidence of such diseases means researchers are experiencing a ‘bounce back’. Tetsuyuki explains how the financial returns for Dementia is not what is spurring this…

April 28, 2016 - 1 minutemin - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Alzheimer's

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

Polish Selvita’s Inflammation Research used to start new Biotech in Scotland

Biotech from the Bermuda Islands Brings Good News for Dementia Patients

Startup Creator Launched to Fill Europe’s Microbiome Translational Gap

This New Biotech wants to Regrow Neurons to cure Parkinson’s

Get to Know the Top 50 Women in the UK’s Biotech Scene

Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close

5 Cool Biotechs in Eastern Europe

CRISPR Gets Snubbed Again by the Nobel Prize Committee

French Biotech bids for Crowdfunding in Neurodegenerative Disease

Cambridge Biotech Raises €32M Series A Round to Treat Chronic Inflammation

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!